December S&P 500 futures (ESZ22) are trending up +0.31% this morning after three major US benchmark indices finished the regular session sharply lower after protests in major Chinese cities against strict...
Four of the biotech's top managers reveal they've exercised stock options, and investors are following suit by snapping up shares.
One is even a technology stock.
The biotech is rebounding after yesterday's big sell-off.
Investors appeared to take profits off the table after the biotech's positive news last week.
A specialty cancer therapy developed by the company shows some rather promising results.
Shorts appear to be moving to the sidelines ahead of an upcoming presentation.
The biotech's stock is giving back some of its recent gains.
The rise was part of an upswing that began earlier this year.
The cell therapy company's shares have been crushing it this year.